Ullman Gives Insight on FDA Warnings Letters

April 18, 2019 | Compliance Investigations & White Collar | Health Services

Marc Ullman was quoted in a NutraIngredients-USA article, “FDA sends warnings letters on illegal ingredients in sports, weight loss products.” The article discusses the 11 warning letters that were sent to companies that have non NDI ingredients in their products. Eight of the warning letters concerned DMHA and the other three concerned phenibut.

Ullman has said previously that the warning letters are at least a step in the right direction. But it remains to be seen how much priority this will be given in the future.

“So now they sent out eight warning letters this morning on DMHA, and three on phenibut. Interestingly, I don’t see either on this [Advisory] list. For this to have any real meaning, they need to get these ingredients on this list, or substances – I don’t even want to dignify them by calling them ingredients,” Ullman told NutraIngredients-USA.

“They’re giving broad public notice that FDA believes DMHA and phenibut are illegal ingredients, and any company that continues to sell them needs to get the message that they may be subject to prosecution. But if all you do is publish a list, and then do nothing, there’s no deterrent effect. Nothing changes,” Ullman informed.

Click here to read the full article.


Share this article:

Related News

Get legal updates and news delivered to your inbox